Shares in drug development company Actinogen Medical (ASX: ACW) have plummeted following the results release of their Phase 2a clinical…
Neuroscience tech company Cogstate (ASX: CGS) has re-acquired the global rights to its technology previously exclusively licensed to Japanese pharma…
Most people experience some level of cognitive decline as they get older. It’s a cruel, albeit normal part of the…
Our minds can be our greatest asset and our biggest enemy. The same humans that built aeroplanes, rockets and the…